Mapfre SaBME: MAP

Half-year information (IPP) 12M 2025

· MarketScreener
Watch Mapfre Sa explain itMapfre, S.A. (MPFRF) Q2 2026 Earnings Call · Replay · Jul 24
APPENDIX III

MAPFRE, S.A. 2nd HALF 2025

INSURANCE ENTITIES

2025

2nd

FINANCIAL INFORMATION CORRESPONDING TO THE YEAR

12/31/2025

PERIOD END DATE

I. COMPANY INFORMATION

Company name: MAPFRE, S.A.

Registered address:

Carretera de Pozuelo, 52. 28222 Majadahonda (Madrid)

C.I.F.

A08055741

II. ADDITIONAL INFORMATION TO THE INFORMATION PUBLISHED FOR THE PREVIOUS HALF-YEAR

Explanation of the key changes with respect to the information published for the previous period:

(only to be completed in the circumstances established in section B) of the instructions)

In the comments section of the consolidated information where relevant, the correspondence has been indicated between EU-IFRS 4 and EU-IAS 39 from the formula and the EU-IFRS 9 & 17 headings from the CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS.

Additionally, the consolidated information for the previous year has been restated for the purpose of comparative.

IV. SELECTED FINANCIAL INFORMATION

1. INDIVIDUAL BALANCE SHEET (1/2)

(PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA)

Units: Thousand euros

ASSETS

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

1. Cash and other equivalent liquid assets

0005

38.160

20.053

2. Financial assets held for trading

0010

3. Other financial assets at fair value, with changes in profit and loss account

0015

4. Financial assets available for sale

0020

79.074

68.659

5. Loans and receivables

0025

288.417

281.898

6. Investments held to maturity

0030

7. Hedging derivatives

0035

8. Participation of reinsurance in technical provisions

0041

9. Property, plant and equipment, and real estate investments:

0045

12.721

12.634

a) Property, plant and equipment

0046

12.721

12.634

b) Real estate investments

0047

10. Intangible assets

0050

15

18

a) Goodwill

0051

b) Acquistion costs of portfolios

0053

c) Other intangible assets

0052

15

18

11. Equity investments in Group and associated companies

0055

10.161.015

10.170.668

a) Associated companies

0056

b) Multigroup companies

0057

c) Group companies

0058

10.161.015

10.170.668

12. Tax assets

0060

127.221

69.632

a) Current tax assets

0061

49.383

10.976

b) Deferred tax assets

0062

77.838

58.656

13. Other assets

0075

0

14. Assets held for sale

0080

TOTAL ASSETS

0100

10.706.623

10.623.562

IV. SELECTED FINANCIAL INFORMATION

1. INDIVIDUAL BALANCE SHEET (2/2)

(PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA)

Units: Thousand euros

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

LIABILITIES AND EQUITY

TOTAL LIABILITIES

0170

3.049.743

2.881.432

1. Financial liabilities held for trading

0110

2. Other financial liabilities at fair value, with changes in profit and loss account

0115

0

3. Debts:

0120

3.009.511

2.847.567

a) Subordinated liabilities

0121

1.631.341

1.629.850

b) Bonds and other negotiable securities

0122

865.644

864.913

c) Debts with credit institutions

0123

85.030

d) Other debts

0124

512.526

267.774

4. Hedging derivatives

0130

5. Technical provisions

0131

a) For unearned premiums

0132

b) For risks in progress

0133

c) For life assurance

0134

d) For outstanding claims

0135

e) For profit sharing and returned premiums

0136

f) Other technical provisions

0137

6. Non-technical provisions

0140

29.366

28.978

7. Tax liabilities:

0145

10.866

3.065

a) Current tax liabilities

0146

7.630

b) Deferred tax liabilities

0147

3.236

3.065

8. Other liabilities

0150

1.822

9. Liabilities linked to assets held for sale

0165

TOTAL NET EQUITY

0195

7.656.880

7.742.130

SHAREHOLDERS' EQUITY

0180

7.647.494

7.736.647

1. Share capital or mutual fund:

0171

307.955

307.955

a) Declared capital or mutual fund

0161

307.955

307.955

b) Less: Uncalled capital

0162

2. Share premium

0172

3.338.720

3.338.720

3. Reserves

0173

3.612.650

3.611.534

4. Less: Treasury stock and own shares

0174

(52.010)

(25.543)

5. Previous years' results

0178

211.423

194.540

6. Other contributions from partners

0179

7. Results for the year

0175

444.325

509.612

8 Less: Interim dividend

0176

(215.569)

(200.171)

9. Other equity instruments

0177

0

VALUATION ADJUSTMENTS

0188

9.386

5.483

1. Financial assets available for sale

0181

9.386

5.483

2. Hedging operations

0182

3. Foreign exchange differences

0184

4. Correction for accounting asymmetries

0185

5. Other adjustments

0187

SUBSIDIES, DONATIONS AND LEGACIES RECEIVED

0193

TOTAL LIABILITIES AND EQUITY

0200

10.706.623

10.623.562

IV. SELECTED FINANCIAL INFORMATION

2. INDIVIDUAL PROFIT AND LOSS ACCOUNT

(PREPARED IN ACCORDANCE WITH CURRENT NATIONAL ACCOUNTING CRITERIA)

Units: Thousand euros

CURRENT PERIOD

(2nd HALF)

PREVIOUS PERIOD

(2nd HALF)

ACCUMULATED

CURRENT YEAR 12/31/2025

ACCUMULATED

PREVIOUS YEAR 12/31/2024

(+) 1. Premiums allocated to the period, net

0201

(+) 2. Revenue from property and other investments

0202

(+) 3. Other technical revenue

0203

(-) 4. Net claims incurred

0204

(+/-) 5. Net variation of other technical provisions

0205

(+/-) 6. Profit sharing and returned premiums

0206

(-) 7. Net operating expenses

0207

(+/-) 8. Other technical expenses

0209

(-) 9. Expenses from property and other investments

0210

A) TECHNICAL RESULT FROM NON-LIFE OPERATIONS (1+ 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9)

0220

(+) 10. Premiums allocated to the period, net

0221

(+) 11. Revenue from property and other investments

0222

(+) 12. Revenue from investments on account of the life policyholders bearing the investment risk

0223

(+) 13. Other technical revenue

0224

(-) 14. Net claims incurred

0225

(+/-) 15. Net variation of other technical provisions

0226

(+/-) 16. Profit sharing and returned premiums

0227

(-) 17. Net operating expenses

0228

(+/-) 18.Other technical expenses

0229

(-) 19. Expenses from property and other investments

0230

(-) 20. Expenses from investments on account of the life policyholders bearing the investment risk

0231

B) TECHNICAL RESULT FROM LIFE OPERATIONS (10 + 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18 + 19 + 20)

0240

C) TECHNICAL RESULT (A + B)

0245

(+) 21. Revenue from property and other investments

0246

310.142

399.275

636.162

652.767

(-) 22. Expenses from property and other investments

0247

(42.725)

(48.224)

(83.488)

(91.971)

(+) 24. Other revenue

0248

51.328

57.463

90.096

88.740

(-) 25. Other expenses

0249

(134.031)

(96.915)

(239.887)

(184.679)

E) RESULT BEFORE TAX (C + 21 + 22 + 23 + 24 + 25)

0265

184.714

311.599

402.883

464.857

(+/-) 26. Corporate Income Tax

0270

20.756

22.739

41.442

44.755

F) RESULT FOR THE PERIOD FROM ONGOING OPERATIONS (E + 26)

0280

205.470

334.338

444.325

509.612

(+/-) 27.Result after tax from discontinued operations

0285

G) RESULT FOR THE PERIOD (F + 27)

0300

205.470

334.338

444.325

509.612

EARNINGS PER SHARE

Basic

0290

0,07

0,11

0,17

0,17

Diluted

0295

0,07

0,11

0,17

0,17

IV. SELECTED FINANCIAL INFORMATION

3. STATEMENT OF RECOGNISED INDIVIDUAL INCOME AND EXPENSES

(PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA)

Units: Thousand euros

CURRENT

PERIOD 12/31/2025

PREVIOUS PERIOD

12/31/2024

A) RESULT FOR THE PERIOD

0305

444.325

509.612

B) OTHER RECOGNISED REVENUE / (EXPENSES)

0310

3.903

1.959

1. Financial assets available for sale:

0315

3.903

1.959

a) Gains/(Losses) due to valuation

0316

5.204

2.612

b) Amounts transferred to the income statement

0317

(1.301)

(653)

c) Other reclassifications

0318

2. Cash flow hedging:

0320

a) Gains/(Losses) due to valuation

0321

b) Amounts transferred to the income statement

0322

c) Amounts recognised at initial value of hedged items

0323

d) Other reclassifications

0324

3. Hedging of net investments in businesses abroad:

0325

a) Gains/(Losses) due to valuation

0326

b) Amounts transferred to the income statement

0327

c) Other reclassifications

0328

4. Foreign exchange differences:

0330

a) Gains/(Losses) due to valuation

0331

b) Amounts transferred to the income statement

0332

c) Other reclassifications

0333

5. Correction of accounting asymmetries:

0335

a) Gains/(Losses) due to valuation

0336

b) Amounts transferred to the income statement

0337

c) Other reclassifications

0338

6. Assets held for sale:

0340

a) Gains/(Losses) due to valuation

0341

b) Amounts transferred to the income statement

0342

c) Other reclassifications

0343

7. Actuarial gains/(losses) for long-term remuneration for employees

0345

8. Other recognised revenue and expenses

0355

9. Corporate Income Tax

0360

TOTAL RECOGNISED REVENUE/(EXPENSES) (A+B)

0400

448.228

511.571

IV. SELECTED FINANCIAL INFORMATION

4. STATEMENT OF CHANGES IN INDIVIDUAL EQUITY (1/2)

(PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA)

EQUITY

Adjustments for changes in value

Subisidies, donations and legacies received

Total equity

Capital or mutual fund

Share premium and other reserves (1)

Treasury stock and own shares

Result for the period

Other equity instruments

Units: Thousand euros

CURRENT PERIOD

Opening balance at 01/01/2025

3010

307.955

6.944.623

(25.543)

509.612

5.483

7.742.130

Adjustments for changes in accounting criteria

3011

Adjustments for errors

3012

Adjusted opening balance

3015

307.955

6.944.623

(25.543)

509.612

5.483

7.742.130

I. Total recognised revenue / (expenses)

3020

444.325

3.903

448.228

II. Operations with shareholders or owners

3025

(507.010)

(26.467)

(533.477)

1. Capital increases (decreases)

3026

2. Conversion of financial liabilities to equity

3027

3. Distribution of dividends

3028

(512.746)

(512.746)

4. Operations involving treasury stock or own shares

3029

5.736

(26.467)

(20.731)

5. Increases / (Decreases) due to changes in business combinations

3030

6. Other operations with shareholders or owners

3032

III. Other variations in equity

3035

509.611

(509.612)

(1)

1. Payments using equity instruments

3036

2. Transfers between equity items

3037

509.612

(509.612)

3. Other variations

3038

(1)

Closing balance as at 12/31/2025

3040

307.955

6.947.224

(52.010)

444.325

9.386

7.656.880

(1) The column "Share premium and other reserves", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend

IV. SELECTED FINANCIAL INFORMATION

4. ESTATEMENT OF CHANGES IN INDIVIDUAL EQUITY (2/2)

(PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA)

EQUITY

Adjustments for changes in value

Subisidies, donations and legacies received

Total equity

Capital or mutual fund

Share premium and other reserves (1)

Treasury stock and own shares

Result for the period

Other equity instruments

Units: Thousand euros

PREVIOUS PERIOD

Opening balance at 01/01/2024

(period of comparison)

3050

307.955

7.050.806

(31.675)

370.807

3.524

7.701.417

Adjustments for changes in accounting criteria

3051

Adjustments for errors

3052

Adjusted opening balance

3055

307.955

7.050.806

(31.675)

370.807

3.524

7.701.417

I. Total recognised revenue / (expenses)

3060

509.612

1.959

511.571

II. Operations with shareholders or owners

3065

(476.951)

6.132

(470.819)

1. Capital increases (decreases)

3066

2. Conversion of financial liabilities to equity

3067

3. Distribution of dividends

3068

(477.331)

(477.331)

4. Operations involving treasury stock or own shares

3069

380

6.132

6.512

5. Increases / (Decreases) due to changes in business combinations

3070

6. Other operations with shareholders or owners

3072

III. Other variations in equity

3075

370.768

(370.807)

(39)

1. Payments using equity instruments

3076

2. Transfers between equity items

3077

370.807

(370.807)

3. Other variations

3078

(39)

(39)

Closing balance as at 12/31/2024 (period of comparison)

3080

307.955

6.944.623

(25.543)

509.612

5.483

7.742.130

(1) The column "Share premium and other reserves", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend

SELECTED FINANCIAL INFORMATION

IV. SELECTED FINANCIAL INFORMATION

5.A. INDIVIDUAL CASH FLOW STATEMENT (DIRECT METHOD)

(Prepared in accordance with current national accounting criteria)

MAPFRE, S.A. 2nd HALF 2025

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

A) NET CASH FLOW FROM OPERATING ACTIVITIES (1 + 2 + 3)

7435

(87.147)

(42.088)

1. Insurance activities:

7405

(+) Inflows from insurance activities

7406

(-) Outflows from insurance activities

7407

2. Other operating activities:

7410

(108.907)

(95.858)

(+) Other operating activities cash inflows

7415

110.370

95.564

(-) Other operating activities cash outflows

7416

(219.277)

(191.422)

3. Inflows /(outflows) due to corporate income tax

7425

21.760

53.770

B) NET CASH FLOW FROM INVESTMENT ACTIVITIES (1 + 2)

7460

607.169

643.159

1. Inflows from investment activities:

7450

642.247

665.426

(+) Tangible assets

7451

(+) Investments in property, plant and equipment

7452

(+) Intangible assets

7453

(+) Financial instruments

7454

(+) Participations

7455

7.869

14.953

(+) Other business units

7457

(+) Interests collected

7456

2.431

2.762

(+) Dividends collected

7459

631.947

647.711

(+) Other income related to investment activities

7458

2. Payments related to investment activities:

7440

(35.078)

(22.267)

(-) Tangible assets

7441

(-) Investments in property, plant and equipment

7442

(-) Intangible assets

7443

(-) Financial instruments

7444

(-) Participations

7445

(35.078)

(22.267)

(-) Other business units

7447

(-) Other payments related to investment activities

7448

C) NET CASH FLOW FROM FINANCING ACTIVITIES (1 + 2)

7490

(501.915)

(592.380)

1. Inflows from financing activities:

7480

736.882

827.511

(+) Subordinated liabilities

7481

(+) Inflows from the issue of equity instruments and capital increases

7482

(+) Capital contributions from owners or mutual members

7483

(+) Sales of treasury stock

7485

7.382

6.511

(+) Other income related to financing activities

7486

729.500

821.000

2. Payments related to financing activities:

7470

(1.238.797)

(1.419.891)

(-) Dividends to shareholders

7471

(498.291)

(477.313)

(-) Interest payments

7475

(80.060)

(87.078)

(-) Subordinated liabilities

7472

(-) Capital contributions returned to shareholders

7473

(-) Capital contributions returned to owners or mutual members

7474

(-) Acquisition of treasury stock

7477

(40.446)

(-) Other payments related to financial activities

7478

(620.000)

(855.500)

D) FOREIGN EXCHANGE DIFFERENCES

7492

E) NET INCREASE / (DECREASE) IN CASH AND EQUIVALENTS (A + B + C + D)

7495

18.107

8.691

F) OPENING CASH BALANCE AND EQUIVALENTS

7499

20.053

11.362

G) CLOSING CASH BALANCES AND EQUIVALENTS (E + F)

7500

38.160

20.053

COMPONENTS OF CASH AND EQUIVALENTS AT PERIOD END

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

(+) Cash and banks

7550

38.160

20.053

(+) Other financial assets

7552

(-) Less: Bank overdrafts payable on demand

7553

TOTAL CLOSING CASH AND EQUIVALENTS

7600

38.160

20.053

SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

6. CONSOLIDATED BALANCE SHEET (IFRS) (1/2)

Units: Thousand euros

CURRENT

PERIOD 12/31/2025

PREVIOUS

PERIOD 12/31/2024

ASSETS

1. Cash and other equivalent liquid assets

1005

1.947.424

1.746.683

2. Financial assets held for trade

1010

3. Other financial assets at fair value, with changes in profit and loss account

1015

17.488.430

15.395.687

4. Financial assets available for sale

1020

23.297.394

23.179.464

5. Loans and receivables

1025

2.107.860

2.153.977

6. Investments held to maturity

1030

1.265.730

1.269.163

7. Hedging derivatives

1035

14

250

8. Participation of reinsurance in technical provisions

1041

5.616.035

6.075.076

9. Property, plant and equipment, and real estate investments

1045

2.175.350

2.068.513

a) Property, plant and equipment

1046

1.194.777

1.213.395

b) Real estate investments

1047

980.573

855.118

10. Intangible assets:

1050

2.322.142

2.540.468

a) Goodwill

1051

1.238.984

1.361.085

b) Acquistion costs of portfolios

1053

280.108

331.928

c) Other intangible assets

1052

803.050

847.455

11. Participation in equity-accounted entities

1055

1.292.614

1.266.578

12. Tax assets

1060

526.249

552.302

a) Current tax assets

1061

228.804

160.438

b) Deferred tax assets

1062

297.445

391.864

13. Other assets

1075

362.338

406.947

14. Assets held for sale

1080

111.217

51.824

TOTAL ASSETS

1100

58.512.797

56.706.932

EU-IFRS 4 and EU-IAS 39 / EU-IFRS 9 and 17

  1. Cash and other cash equivalents / I) CASH

  2. Trading portfolio / N/A

  3. Other financial assets at fair value, with changes in profit and loss account/ C.II.1. Financial investments at fair value with changes through

  4. Financial assets available for sale / C.II.2 Financial investments at fair value with changes through OCI

  5. Loans and receivables / H.I.2. Other tax receivables, H.II. Corporate and other receivables, H.III. Shareholders, called capital, C.V. Other i

  6. Held to maturity investment portfolio / C.II.3. Financial investments at amortized cost

  7. Hedging derivates / C.IV. Hedging instruments

  8. Participation of reinsurance in technical provisions / E) CEDED REINSURANCE CONTRACT ASSETS

  9. Property, plant and equipment, and real estate investments

    1. Property, plant and equipment /B) PROPERTY, PLANT AND EQUIPMENT

    2. Real estate investments / C.I. Real estate for own use

  10. Intangible assets:

    1. Goodwill/ A.I. Goodwill

    2. Acquistion costs of portfolios/ / A.II.Other intangible assets. 1. Portfolio acquisition expenses

    3. Other intangible assets / A.II. Other intangible assets. 2. Other intangible fixed assets

  11. Participation in equity-accounted entities / C.III. Equity-accounted investments; C.V. Other investments. Investments - Shares in Group an

  12. Tax assets:

    1. Current tax assets/ H.I.1. Tax credits on profits

    2. Deferred tax assets / G) DEFERRED TAX ASSETS

  13. Other assets / D) INSURANCE CONTRACT ASSETS, F) INVENTORIES, J) ACCRUAL ADJUSTMENTS, K) OTHER ASSETS

  14. Assets held for sale / / L) NON-CURRENT ASSETS HELD FOR SALE AND FROM DISCONTINUED OPERATIONS

SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

6. CONSOLIDATED BALANCE SHEET (IFRS) (2/2)

Units: Thousand euros

CURRENT

PERIOD 12/31/2025

PREVIOUS

PERIOD 12/31/2024

LIABILITIES AND EQUITY

TOTAL LIABILITIES

1170

47.998.627

46.721.453

1. Financial liabilities held for trade

1110

2. Other financial liabilities at fair value, with changes in profit and loss account

1115

1.815.930

1.432.363

3. Debts:

1120

4.369.317

4.356.856

a) Subordinated liabilities

1121

1.631.340

1.629.850

b) Bonds and other negotiable securities

1122

865.645

864.913

c) Debts with credit institutions

1123

125.037

177.968

d) Other debts

1124

1.747.295

1.684.125

4. Hedging derivatives

1130

7.168

5. Technical provisions

1131

40.540.579

39.792.881

a) For unearned premiums

1132

5.796.198

5.898.468

b) For risks in progress

1133

c) For life assurance

1134

21.195.590

20.441.194

d) For outstanding claims

1135

13.548.791

13.453.219

e) For profit sharing and returned premiums

1136

f) Other technical provisions

1137

6. Non-technical provisions

1140

640.899

570.901

7. Tax liabilities:

1145

505.779

408.716

a) Current tax liabilities

1146

247.626

213.167

b) Deferred tax liabilities

1147

258.153

195.549

8. Other liabilities

1150

104.446

142.218

9. Liabilities linked to assets held for sale

1165

21.677

10.350

TOTAL NET EQUITY

1195

10.514.170

9.985.479

SHAREHOLDERS' EQUITY

1180

11.401.415

10.782.072

1. Share capital or mutual fund:

1171

307.955

307.955

a) Declared capital or mutual fund

1161

307.955

307.955

b) Less: Uncalled capital

1162

2. Share premium

1172

1.506.729

1.506.729

3. Reserves

1173

8.056.177

7.576.868

4. Less: Treasury stock and own shares

1174

(52.010)

(25.543)

5. Previous years' results

1178

665.577

648.707

6. Other contributions from partners

1179

7. Results for the year

1175

1.132.555

967.527

8 Less: Interim dividend

1176

(215.568)

(200.171)

9. Other equity instruments

1177

OTHER ACCUMULATED COMPREHENSIVE INCOME

1188

(1.991.647)

(1.893.402)

1. Items not reclassifed to the result of the period

1190

2. Items that can be subsequently reclassified to the result of the period

1183

(1.991.647)

(1.893.402)

a) Financial assets available for sale

1181

(92.979)

(198.543)

b) Hedging operations

112

c) Foreign exchange differences

1184

(1.773.644)

(1.440.009)

d) Correction for accounting asymmetries

1185

(131.209)

(307.415)

e) Equity-accounted entities

1186

8.090

9.117

f) Other adjustments

1187

(1.905)

43.448

NET EQUITY ATTRIBUTABLE TO THE CONTROLLING COMPANY

1189

9.409.768

8.888.670

NON-CONTROLLING INTERESTS

1193

1.104.402

1.096.809

TOTAL LIABILITIES AND NET EQUITY

1200

58.512.797

56.706.932

EQUITY AND LIABILITIES

NIIF-UE 4 y NIC-UE 39 / NIIF-UE 9 y 17 TOTAL LIABILITIES

  1. Financial liabilities held for trade/ N/A

  2. Other financial liabilities at fair value, with changes in profit and loss account / G.III. Other financial liabilities

  3. Debts: a) Subordinated liabilities / B) SUBORDINATED LIABILITIES

    1. Bonds and other negotiable securities/ G.I. Issue of debentures and other trading securities

    2. Debts with credit institutions / G.II. Due to credit institutions

    3. Other debts / G.V.2. Other tax liabilities, G.VI. Other debts

  4. Hedging derivatives / G.IV. Derivatives for hedging

  5. Technical provisions: a) For unearned premiums/ C.V. Measurement under PAA for Liabilities for remaining coverage

    1. For risks in progress/ N/A

    2. For life assurance/ C.I. Measurement under BBA for Liabilities for remaining coverage, C.II. Measurement under BBA for Liabilities for incurred claims, Measurement under VFA for Liabilities for incurred claims C.III. Measurement under VFA for Liabilities for remaining coverage, C.IV.

    3. For outstanding claims / C.VI. Measurement under PAA for Liabilities for incurred claims

    4. For profit sharing and returned premiums / N/A

    5. Other technical provisions / N/A

  6. Non-technical provisions / E) PROVISIONS FOR RISKS AND EXPENSES

  7. Tax liabilities:

    1. Current tax liabilities / G.V.I. Tax liabilities on profits

    2. Deferred tax liabilities / F. DEFERRED TAX LIABILITIES

  8. Other liabilities/ H) ACCRUAL ADJUSTMENTS, D) CEDED RINSURANCE CONTRACT LIABILITIES

  9. Liabilities linked to assets held for sale / I) LIABILITIES LINKED TO NON-CURRENT ASSETS HELD FOR SALE AND FROM DISCONTINUED ACTIVITIES TOTAL EQUITY

SHAREHOLDERS' EQUITY

  1. Share capital or mutual fund:a) Declared capital or mutual fund / A.I. Paid-up capital. 1 issued capital

    b) Less: Uncalled capital/ A.I. Paid-up capital. 2 Uncalled capital

  2. Share premium/ A.II. Share premium

  3. Reserves / A.III. Reserves

  4. Less: Treasury stock and own shares / A.V. Treasury stock

  5. Previous years' results / A.III. Reserves. 1.Results from previous periods pending application

  6. Other contributions from partners / A.VII. Other equity instruments. Other shareholder contributions

  7. Results for the year / A.VI. Result for the period attributable to the controlling company 8 Less: Interim dividend / A.IV. Interim dividend

9. Other equity instruments/ A.VII. Other equity instruments

OTHER ACCUMULATED COMPREHENSIVE INCOME / A.VIII. Valuation change adjustments

  1. Item not reclassified to the result of the period.

  2. Items that can be subsequently reclasiffied to the result of the period.

    1. Financial assets available for sale/ A.VIII. Financial assets at fair value with changes through OCI

    2. Hedging operations / A.VIII. Hedging

    3. Foreign exchange differences / A.IX. Currency conversion differences

    4. Correction for accounting asymmetries / A.VIII. Insurance contract valuation adjustments

    5. Equity-accounted entities a / A.VIII. Equity-accounted companies

    6. Other adjustments/ A.VIII. Property, plant and equipment revaluation, A.VIII. Assets held for sale, A.VIII. Hedging for

investments net of foreign business, A.VIII. Actuarial gains (losses) for long-term employee remuneration, A.VIII. Other recognized revenue and expenses PATRIMONIO NETO ATRIBUIDO A LA ENTIDAD CONTROLADORA / Equity attributable to the controlling company's shareholders

B.3) NON-CONTROLLING INTERESTS / Non-controlling interests

SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

7. CONSOLIDATED PROFIT AND LOSS ACCOUNT (IFRS)

Units: Thousand euros

STANDALONE

CURRENT PERIOD (2nd HALF)

STANDALONE

PREVIOUS PERIOD (2nd HALF)

ACCUMULATED

CURRENT YEAR 12/31/2025

ACCUMULATED PREVIOUS YEAR

12/31/2024

(+) 1. Premiums allocated to the period, net

1201

9.172.082

8.856.251

18.264.138

17.503.705

(+) 2. Revenue from property and other investments

1202

1.216.762

1.439.343

2.788.200

2.751.489

(+) 3. Other technical revenue

1203

150.692

147.599

306.538

303.386

(-) 4. Net claims incurred

1204

(5.738.790)

(5.809.018)

(11.588.834)

(11.887.232)

(+/-) 5. Net variation of other technical provisions

1205

(275.763)

(327.740)

(603.200)

(310.165)

(+/-) 6. Profit sharing and returned premiums

1206

(-) 7. Net operating expenses

1207

(2.414.476)

(2.221.826)

(4.726.111)

(4.448.443)

(+/-) 8. Other technical expenses

1209

(-) 9. Expenses from property and other investments

1210

(941.660)

(1.164.180)

(2.253.070)

(2.206.398)

TECHNICAL RESULT FROM NON-LIFE OPERATIONS

A) (1+ 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9)

1220

1.168.847

920.429

2.187.661

1.706.342

(+) 10. Premiums allocated to the period, net

1221

1.017.216

924.533

1.940.333

1.905.253

(+) 11. Revenue from property and other investments

1222

1.137.170

703.877

2.037.294

1.798.847

(+) 12. Revenue from investments on account of the life policyholders bearing the investment risk

1223

(+) 13. Other technical revenue

1224

841.009

810.249

1.712.787

1.527.649

(-) 14. Net claims incurred

1225

(993.988)

(893.743)

(1.880.099)

(1.733.284)

(+/-) 15. Net variation of other technical provisions

1226

(13.690)

(62.829)

12.185

(28.191)

(+/-) 16. Profit sharing and returned premiums

1227

(-) 17. Net operating expenses

1228

(693.912)

(570.208)

(1.324.769)

(1.128.781)

(+/-) 18.Other technical expenses

1229

(-) 19. Expenses from property and other investments

1230

(1.039.787)

(637.652)

(1.884.952)

(1.686.657)

(-) 20. Expenses from investments on account of the life policyholders bearing the investment risk

1231

TECHNICAL RESULT FROM LIFE OPERATIONS (10 + B) 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18 + 19 + 20)

1240

254.018

274.227

612.779

654.836

C) TECHNICAL RESULT (A + B)

1245

1.422.865

1.194.656

2.800.440

2.361.178

(+) 21. Revenue from property and other investments

1246

38.020

37.868

75.575

68.505

(-) 23. Expenses from property and other investments

1247

(67.450)

(65.506)

(126.944)

(123.925)

(+) 24. Other revenue

1248

343.721

315.417

672.607

692.892

(-) 25. Other expenses

1249

(457.152)

(414.271)

(896.947)

(898.829)

E) RESULT BEFORE TAX (C + 21 + 22 + 23 + 24 + 25)

1265

1.280.004

1.068.164

2.524.731

2.099.824

(+/-) 26. Corporate Income Tax

1270

(401.261)

(270.972)

(727.517)

(512.529)

RESULT FOR THE PERIOD FROM ONGOING

F) OPERATIONS (E + 26)

1280

878.743

797.192

1.797.214

1.587.295

(+/-) 27.Result after tax from discontinued operations

1285

G) RESULT FOR THE PERIOD (F + 27)

1288

878.743

797.192

1.797.214

1.587.295

a) Result attributable to the controlling company

1300

536.624

473.571

1.132.555

967.527

b) Result attributable to non-controlling interests

1289

342.119

323.621

664.659

619.768

EARNINGS PER SHARE

Amount (X,XX euros)

Amount (X,XX euros)

Amount (X,XX euros)

Amount (X,XX euros)

Reported

1290

0,17

0,15

0,37

0,31

Diluted

1295

0,17

0,15

0,37

0,31

In the six month financial report corresponding to the first half of the year, the data relating to the current period coincides with the accumulated data, and therefore does not need to be filled in.

NIIF-UE 4 y NIC-UE 39 / NIIF-UE 9 y 17

NON-LIFE INSURANCE TECHNICAL ACCOUNT

  1. Premiums allocated to the period, net/ I.1. Release of liabilities for remaining coverage. Release of premium (PAA).

  2. Revenue from property and other investments / V.1.Insurance and reinsurance finance revenue, VI.1.Finance revenue not related to Insurance service,

    VI.4. Reversal of financial asset impairment, VI.3.a. Share in profits from equity-accounted Companies, VII.3. Positive exchange differences

  3. Other technical revenue / I.1. Release of liabilities for remaining coverage. Claims and other expected Insurance service expenses. Changes in the non-

    financial risk adjustment. Release of CSM, I.2. Release of acquisition expenses allocated to the period

  4. Net claims incurred / II.1. Claims and other Insurance service expenses. Claims, II.3. Losses on groups of onerous contracts and reversals of these losses, III. Amount recoverable from reinsurers. Amount recoverable from claims and other expenses

  5. Net variation of other technical provisions/ II.4. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers. Changes in liabilities for

    incurred claims, III. Amount recoverable from reinsurers. Changes in cash flows related to onerous underlying contracts

  6. Profit sharing and returned premiums/ N/A

  7. Net operating expenses/ II.1. Claims and other Insurance Service expenses. Other fulfillment expenses. II.2. Acquisition expenses.

  8. Other technical expenses/ N/A

  9. Expenses from property and other investments / V.2. Insurance and reinsurance contract finance expenses, VI.2. Finance expenses not related to insurance contracts, VII.4. Negative Exchange differences, VI.5. Allowance to the financial asset impairment provision, VII.6. Allowance to the asset impairment

    LIFE INSURANCE TECHNICAL ACCOUNT

  10. Premiums allocated to the period, net/ I.1. Release of liabilities for remaining coverage. Release of premium (PAA).

  11. Revenue from property and other investments / V.1.Insurance and reinsurance contract finance revenue, VI.1. Finance revenue not related to Insurance contracts, VI.4. Reversal of financial asset impairment provision, VI.3.a. Share in profits from equity-accounted companies, VII.3. Positive exchange differences

  12. Revenue from investments on account of the life policyholders bearing the investment risk/ N/A

  13. Other technical revenue/ I.1. Release of liability for remaining coverage. Claims and other expected Insurance service expenses. Changes in the adjustment for non-financial risk. Release of CSM, I.2. Release of acquisition expenses allocated to the period

  14. Net claims incurred/ II.1. Claims and other Insurance service expenses. Claims, II.3. Losses on groups of onerous contracts and reversals of these losses,

    III. Amount recoverable from reinsurers. Amounts recoverable for claims and other expenses

  15. Net variation of other technical provisions/ II.4. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers, Changes in cash flows related to onerous underlying contracts

  16. Profit sharing and returned premiums / N/A

  17. Net operating expenses/ II.1. Claims and other Insurance service expenses. Other fulfillment expenses. II.2. Acquisition expenses.

  18. Other technical expenses / N/A

  19. Expenses from property and other investments/ V.2. Insurace and reinsurance contract finance expenses, VI.2. Finance expenses not related to Insurance contracts, VII.4. Negative conversion differences, VI.5. Allowance to the financial asset impairment provision, VII.6. Allowance to the asset impairment

  20. Expenses from investments on account of the life policyholders bearing the investment risk/ N/A NON-TECHNICAL ACCOUNT

  21. Revenue from property and other investments / VIII.3. Revenue from fixed assets and investments, VIII.5. Net financial income. Group and associated

    company dividends. Other

  22. Expenses from property and other investments/ VIII.4. Expenses from fixed assets and investments, VIII.5. Net financial income. Financial expenses

  23. Other revenue / VIII.1. Operating revenue, VIII.10. Reversal to the asset impairment provision VII.1. Other non-technical revenue, VIII.7.a. Share in profits from equity-accounted companies, VIII.8. Positive Exchange differences

  24. Other expenses / VIII.2. Operating expenses, VIII.11. Allowance to the asset impairment provision, VII.2. Other non-technical expenses, VIII.7.b. Share in

losses from equity-accounted companies, VIII.9. Negative Exchange differences

  1. RESULT BEFORE TAX/ X. RESULT BEFORE TAX FROM ONGOING OPERATIONS

    26. Corporate Income Tax/ XI. TAX ON PROFIT FROM ONGOING OPERATIONS

  2. RESULT FOR THE PERIOD FROM ONGOING OPERATIONS / XII. RESULT AFTER TAX FROM ONGOING OPERATIONS

    26.Result after tax from discontinued operations / XIII. RESULT AFTER TAX FROM DISCONTINUED OPERATIONS

  3. RESULT FOR THE PERIOD FROM ONGOING OPERATIONS/ XIV.RESULT FOR THE PERIOD

G) RESULT FOR THE PERIOD: a) Result attributable to the controlling company / XIV.2.Attributable to the controlling company

G) RESULT FOR THE PERIOD: b) Result attributable to non-controlling interests / XIV.1.Attributable to non-controlling interests

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

8. OTHER COMPREHENSIVE INCOME (IFRS ADOPTED)

Units: Thousand euros

STANDALONE

CURRENT PERIOD (2nd HALF)

STANDALONE

PREVIOUS PERIOD (2nd HALF)

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

A) CONSOLIDATED PROFIT AND LOSS OF THE YEAR

1305

878.743

797.192

1.587.295

B) OTHER GLOBAL RESULTS - ITEMS NOT RECLASSIFIED TO THE RESULT FOR THE PERIOD

1310

9.400

23.391

45.991

1. Actuarial gains/(losses) for long-term remuneration for employees:

1370

2. Participation in other recognized global results from investments in joint and associated businesses:

1371

3. Other income and expenses not reclassfied to the result for the period:

1372

9.400

23.391

45.991

4. Tax effect:

1373

C) OTHER GLOBAL RESULTS - ITEMS THAT CAN BE SUBSEQUENTLY RECLASSIFIED TO THE RESULT FOR

THE PERIOD

1345

136.831

18.090

(220.863)

1. Financial assets available for sale:

1315

94.718

312.147

(119.248)

a) Gains/(Losses) due to valuation

1316

97.933

319.948

(66.756)

b) Amounts transferred to the income statement

1317

(649)

2.452

(27.633)

c) Other reclassifications

1318

(2.566)

(10.253)

(24.859)

2. Cash flow hedging:

1320

83.062

(308.212)

(33.494)

a) Gains/(Losses) due to valuation

1321

83.062

(308.212)

(33.494)

b) Amounts transferred to the income statement

1322

c) Amounts recognised at initial value of hedged items

1323

d) Other reclassifications

1324

3. Hedging of net investments in businesses abroad:

1325

a) Gains/(Losses) due to valuation

1326

b) Amounts transferred to the income statement

1327

c) Other reclassifications

1328

4. Foreign exchange differences:

1330

(21.565)

(940)

(123.571)

a) Gains/(Losses) due to valuation

1331

(21.600)

(3.081)

(125.314)

b) Amounts transferred to the income statement

1332

35

2.141

1.743

c) Other reclassifications

1333

5. Correction of accounting asymmetries:

1335

a) Gains/(Losses) due to valuation

1336

b) Amounts transferred to the income statement

1337

c) Other reclassifications

1338

6. Assets held for sale:

1340

a) Gains/(Losses) due to valuation

1341

b) Amounts transferred to the income statement

1342

c) Other reclassifications

1343

7. Participation in other recognized global results from investments in joint and associated businesses:

1350

(66)

(1.934)

(12.099)

a) Gains/(Losses) due to valuation

1351

(66)

(1.196)

(3.076)

b) Amounts transferred to the income statement

1352

c) Other reclassifications

1353

(738)

(9.023)

8. Other income and expenses that can be subsequently reclassified to the result for the period

1355

8.885

958

2.401

9. Tax effect

1360

(28.203)

16.071

65.149

TOTAL GLOBAL RESULT FOR THE PERIOD (A+B+C)

1400

1.024.974

838.673

1.412.424

a) Attributable to the controlling company

1398

684.951

550.156

886.160

b) Attributable to minority interests

1399

340.023

288.517

526.264

IV. SELECTED FINANCIAL INFORMATION

9. CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (IFRS) (1/2)

Equity of the controlling company

Adjustments for changes in value

Non-controlling interests

Total equity

SHAREHOLDERS' EQUITY

Capital or mutual fund

Share premium and other reserves(1)

Treasury stock and own shares

Result for the period attributable to the controlling company

Other equity instruments

Units: Thousand euros

CURRENT PERIOD

Opening balance as at 01/01/2025

3110

307.955

9.532.133

(25.543)

967.527

(1.893.402)

1.096.809

9.985.479

Adjustments for changes in accounting criteria

3111

Adjustments for errors

3112

Adjusted opening balance

3115

307.955

9.532.133

(25.543)

967.527

(1.893.402)

1.096.809

9.985.479

I. Total revenue/ (expenses) recognized

3120

32.573

1.132.555

(98.245)

656.843

1.723.726

II. Operations with shareholders or owners

3125

(498.387)

(26.467)

(645.369)

(1.170.223)

1. Capital increases (decreases)

3126

16.370

16.370

2. Conversion of financial liabilities to equity

3127

3. Distribution of dividends

3128

(512.746)

(670.600)

(1.183.346)

4. Operations involving treasury stock or own shares

3129

5.736

(26.467)

(20.731)

5. Increases / (Decreases) due to changes in business combinations

3130

6. Other operations with shareholders or owners

3132

8.623

8.861

17.484

III. Other variations in equity

3135

946.594

(967.526)

(3.880)

(24.812)

1. Payments using equity instruments

3136

2. Transfers between equity items

3137

967.526

(967.526)

3. Other variations

3138

(20.932)

(3.880)

(24.812)

Closing balance as at 12/31/2025

3140

307.955

10.012.916

(52.010)

1.132.555

(1.991.648)

1.104.402

10.514.170

(1) The column "Share premium and other reserves", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend

IV. SELECTED FINANCIAL INFORMATION

9. CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (IFRS) (2/2)

Equity of the controlling company

Adjustments for changes in value

Non-controlling interests

Total equity

SHAREHOLDERS' EQUITY

Capital or mutual fund

Share premium and other reserves(1)

Treasury stock and own shares

Result for the period attributable to the controlling company

Other equity instruments

Units: Thousand euros

PREVIOUS PERIOD

Opening balance as at 01/01/2024

3150

307.955

9.279.133

(31.675)

677.215

(1.766.044)

1.189.721

9.656.305

Adjustments for changes in accounting criteria

3151

Adjustments for errors

3152

Adjusted opening balance

3155

307.955

9.279.133

(31.675)

677.215

(1.766.044)

1.189.721

9.656.305

I. Total revenue/ (expenses) recognized

3160

45.991

967.527

(127.358)

526.264

1.412.424

II. Operations with shareholders or owners

3165

(476.951)

6.132

(623.079)

(1.093.898)

1. Capital increases (decreases)

3166

2. Conversion of financial liabilities to equity

3167

3. Distribution of dividends

3168

(477.331)

(621.612)

(1.098.943)

4. Operations involving treasury stock or own shares

3169

380

6.132

6.512

5. Increases / (Decreases) due to changes in business combinations

3170

6. Other operations with shareholders or owners

3172

(1.467)

(1.467)

III. Other variations in equity

3175

683.960

(677.215)

3.903

10.648

1. Payments using equity instruments

3176

2. Transfers between equity items

3177

677.215

(677.215)

3. Other variations

3178

6.745

3.903

10.648

Closing balance as at 12/31/2024

3180

307.955

9.532.133

(25.543)

967.527

(1.893.402)

1.096.809

9.985.479

(1) The column "Share premium and other reserves", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend

SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

10. A. CONSOLIDATED CASH FLOW STATEMENT (DIRECT METHOD) (IFRS)

Units: Thousand euros

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

A) NET CASH FLOW FROM OPERATING ACTIVITIES (1 + 2 + 3)

8435

1.640.793

1.499.371

1. Insurance activites:

8405

2.676.649

2.175.636

(+) Inflows from insurance activities

8406

29.813.712

29.173.931

(-) Outflows from insurance activities

8407

(27.137.063)

(26.998.295)

2. Other operating activities:

8410

(466.057)

(346.066)

(+) Cash inflows from other operating activities

8415

865.584

935.526

(-) Cash outflows from other operating activities

8416

(1.331.641)

(1.281.592)

3. Inflows /(outflows) due to corporate income tax

8425

(569.799)

(330.199)

B) NET CASH FLOW FROM INVESTMENT ACTIVITIES (1 + 2)

8460

(405.179)

(746.938)

1. Inflows from investment activities:

8450

23.807.115

16.729.688

(+) Property, plant and equipment

8451

2.821

2.420

(+) Real estate investment

8452

136.008

153.663

(+) Intangible fixed assets

8453

7

(+) Financial instruments

8454

20.873.767

13.631.109

(+) Investments in associates

8455

1.698.324

1.900.386

(+) Controlled companies and other business units

8457

1.490

6.029

(+) Interests collected

8456

951.159

929.715

(+) Dividends collected

8459

100.731

96.239

(+) Other income related to investment activities

8458

42.815

10.120

2.Payments related to investment activities:

8440

(24.212.294)

(17.476.626)

(-) Property, plant and equipment

8441

(64.974)

(60.092)

(-) Real estate investment

8442

(196.707)

(43.722)

(-) Intangible fixed assets

8443

(152.011)

(227.337)

(-) Financial instruments

8444

(21.525.345)

(15.308.110)

(-) Investments in associates

8445

(2.193.085)

(1.666.933)

(-) Controlled companies and other business units

8447

(20.514)

(81.284)

(-) Other payments related to investment activities

8448

(59.658)

(89.148)

C) NET CASH FLOW FROM FINANCING ACTIVITIES (1 + 2)

8490

(933.931)

(1.088.034)

1. Inflows from financing activities:

8480

895.930

847.379

(+) Subordinated liabilities

8481

(+) Inflows from the issue of equity instruments and capital increases

8482

3.158

(+) Capital contributions from owners or partners

8483

6

(+) Sales of treasury stock

8485

7.382

6.511

(+) Other income related to financing activities

8486

888.548

837.704

2. Payments related to financing activities:

8470

(1.829.861)

(1.935.413)

(-) Dividends to shareholders

8470

(1.183.346)

(1.098.288)

(-) Interest paid

8471

(89.848)

(91.504)

(-) Subordinated liabilities

8472

(-) Capital contributions returned to shareholders

8473

(-) Capital contributions returned to owners or partners

8474

(-) Acquisition of treasury stock

8477

(-) Other payments related to financiing activities

8478

(516.221)

(-) Acquisition of non-controlling interests

8479

(40.446)

(745.621)

D) FOREIGN EXCHANGE DIFFERENCES

8492

(100.949)

(3.664)

E) NET INCREASE / (DECREASE) IN CASH AND EQUIVALENTS (A + B + C + D)

8495

200.734

(339.265)

F) OPENING CASH BALANCE AND EQUIVALENTS

8499

1.746.690

2.085.955

G) CLOSING CASH BALANCES AND EQUIVALENTS (E + F)

8500

1.947.424

1.746.690

CURRENT PERIOD 12/31/2025

PREVIOUS PERIOD 12/31/2024

COMPONENTS OF CASH AND EQUIVALENTS AT PERIOD END

(+) Cash and banks

8550

1.888.391

1.687.297

(+) Other financial assets

8552

59.033

59.393

(-) Less: Bank overdrafts payable on demand

8553

TOTAL CLOSING CASH AND EQUIVALENTS

8600

1.947.424

1.746.690

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

11. DIVIDENDS PAID

CURRENT PERIOD

PREVIOUS PERIOD

Euros per share

(X,XX)

Amount (thousand

Euros)

Total outstanding

share

Euros per share

(X,XX)

Amount (thousand

Euros)

Total outstanding

share

Ordinary shares

2158

0,17

508.200

0,16

447.300

Other shares (non-voting, reedemable, etc)

2159

Total dividends paid

2160

0,17

508.200

0,16

447.300

a) Dividends paid out against results

2155

0,17

508.200

0,16

447.300

b) Dividends paid out against reserves or share premium

2156

c) Dividends in kind

2157

d) Flexible payment

2154

Units: Thousand euros

12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY(1/4)

IV. SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

Units: Thousands of euros

FINANCIAL ASSETS: NATURE/ CATEGORY

CURRENT PERIOD

Financial assets held for trading

Other fiancial assets at FV with changes in P&L

Financial assets available for sale

Loans and receivables

Investments held to maturity

Derivatives

2062

Equity instruments

2063

76.172

Debt securities

2064

2.902

Hybrid instruments

2065

Loans

2066

104.787

Deposits established for accepted reinsurance and other deposits

2067

Receivables on direct insurance, reinsurance, and coinsurance

2068

Investments on behalf of life insurance policy holders bearing investment risk

2069

Other financial assets

2070

183.630

TOTAL (INDIVIDUAL)

2075

79.074

288.417

Derivatives

2162

Equity instruments

2163

6.385.793

1.429.241

Debt securities

2164

10.904.131

21.867.608

1.228.457

Hybrid instruments

2165

95.968

Loans

2166

Deposits established for accepted reinsurance and other deposits

2167

Receivables on direct insurance, reinsurance, and coinsurance

2168

Investments on behalf of life insurance policy holders bearing investment risk

2169

Other financial assets

2170

102.538

545

2.107.860

37.273

TOTAL (CONSOLIDATED)

2175

17.488.430

23.297.394

2.107.860

1.265.730

IV. SELECTED FINANCIAL INFORMATION

12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY (2/2)

Units: Thousands of euros

CURRENT PERIOD

Financial liabilities held for trading

Other fiancial liabilities at FV with changes in P&L

Debts and payables

Derivatives

2076

Subordinated liabilities

2077

1.631.341

Deposits received on ceded reinsurance

2079

Due on direct insurance, reinsurance and coinsurance

operations

2080

Debentures and other negotiable securities

2081

865.644

Due to credit institions

2082

Due on preparatory operationsfor insurance contracts

2083

Other financial liabilities

2084

512.526

TOTAL (INDIVIDUAL)

2090

3.009.511

Derivatives

2176

Subordinated liabilities

2177

1.631.341

Deposits received on ceded reinsurance

2179

Due on direct insurance, reinsurance and coinsurance

operations

2180

Debentures and other negotiable securities

2181

865.644

Due to credit institions

2182

125.037

Due on preparatory operationsfor insurance contracts

2183

Other financial liabilities

2184

1.815.930

1.747.295

TOTAL (CONSOLIDATED)

2190

1.815.930

4.369.317

(Abreviations- FV: Fair Value / P&L: profit and loss account)

12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY (3/4)

IV. SELECTED FINANCIAL INFORMATION

Units: Thousands of euros

FINANCIAL ASSETS: NATURE/ CATEGORY

PREVIOUS PERIOD

Financial assets held for trading

Other fiancial assets at FV with changes in

P&L

Financial assets available for

sale

Loans and receivables

Investments held to maturity

Derivatives

5062

Equity instruments

5063

58.625

Debt securities

5064

10.034

Hybrid instruments

5065

Loans

5066

108.464

Deposits established for accepted reinsurance and

other deposits

5067

Receivables on direct insurance, reinsurance, and

coinsurance

5068

Investments on behalf of life insurance policy holders

bearing investment risk

5069

Other financial assets

5070

173.434

TOTAL (INDIVIDUAL)

5075

0

68.659

281.898

Derivatives

5162

Equity instruments

5163

5.203.578

1.055.993

Debt securities

5164

10.116.437

22.122.543

1.259.143

Hybrid instruments

5165

16.062

Loans

5166

Deposits established for accepted reinsurance and

other deposits

5167

Receivables on direct insurance, reinsurance, and

coinsurance

5168

Investments on behalf of life insurance policy holders

bearing investment risk

5169

Other financial assets

5170

59.610

928

2.153.977

10.020

TOTAL (CONSOLIDATED)

5175

15.395.687

23.179.464

2.153.977

1.269.163

SELECTED FINANCIAL INFORMATION

12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY(4/4)

IV. SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

Units: Thousands of euros

PREVIOUS PERIOD

Financial liabilities held for trading

Other fiancial liabilities at FV with

changes in P&L

Debts and

payables

Derivatives

5076

Subordinated liabilities

5077

1.629.850

Deposits received on ceded reinsurance

5079

Due on direct insurance, reinsurance and coinsurance operations

5080

Debentures and other negotiable securities

5081

864.913

Due to credit institions

5082

85.030

Due on preparatory operationsfor insurance contracts

5083

Other financial liabilities

5084

267.774

TOTAL (INDIVIDUAL)

5090

2.847.567

Derivatives

5176

Subordinated liabilities

5177

1.629.850

Deposits received on ceded reinsurance

5179

Due on direct insurance, reinsurance and coinsurance operations

5180

Debentures and other negotiable securities

5181

864.913

Due to credit institions

5182

177.968

Due on preparatory operationsfor insurance contracts

5183

Other financial liabilities

5184

1.432.363

1.684.125

TOTAL (CONSOLIDATED)

5190

1.432.363

4.356.856

SELECTED FINANCIAL INFORMATION

MAPFRE, S.A. 2nd HALF 2025

IV. SELECTED FINANCIAL INFORMATION

13. INFORMATION BY SEGMENTS

Units: Thousands of euros

Table 1:

GEOGRAPHICAL AREA

Distribution of net premiums attributed to business by geographical area

INDIVIDUAL

CONSOLIDATED

CURRENT

PERIOD

PREVIOUS

PERIOD

CURRENT

PERIOD

PREVIOUS

PERIOD

Domestic market

2210

10.798.127

10.056.720

Exports:

2215

9.406.344

9.352.238

a) European Union

2216

679.834

671.478

a.1) Euro area

2217

679.834

671.478

a.2) No Euro Area

2218

b) Others

2219

8.726.510

8.680.760

TOTAL

2220

20.204.471

19.408.958

Table 2:

CONSOLIDATED

Total ordinary revenues

Result

SEGMENTOS

CURRENT

PERIOD

PREVIOUS

PERIOD

CURRENT

PERIOD

PREVIOUS

PERIOD

IBERIA

2221

9.086.596

8.398.514

685.771

590.329

BRAZIL

2222

4.870.529

5.079.569

1.149.218

1.033.580

OTHER LATAM

2223

5.541.107

5.872.145

91.220

217.564

NORTH AMERICA

2224

2.893.613

2.995.136

172.620

142.030

EMEA

2225

1.653.745

1.520.612

59.151

(44.400)

MAPFRE RE

2226

10.297.488

9.299.529

616.902

453.799

MAPFRE ASISTENCIA

2227

489.019

504.149

12.756

6.574

(-) Adjustments and eliminations of

ordinary revenue between segments

2228

(5.772.201)

(4.998.571)

(262.906)

(299.652)

2229

2230

TOTAL

2235

29.059.896

28.671.083

2.524.732

2.099.824

SELECTED FINANCIAL INFORMATION

IV. SELECTED FINANCIAL INFORMATION

14. AVERAGE WORK FORCE

MAPFRE, S.A. 2nd HALF 2025

INDIVIDUAL

CONSOLIDATED

CURRENT

PERIOD

PREVIOUS

PERIOD

CURRENT

PERIOD

PREVIOUS

PERIOD

AVERAGE WORK FORCE

2295

591

571

30.846

30.602

Men

2296

315

304

13.837

13.654

Women

2297

276

267

17.009

16.948

Remuneration

Amount (thousands of

euros)

CURRENT

PERIOD

PREVIOUS

PERIOD

Remuneration for being a member of the Board and/or Board Committees

2310

3.300

3.000

Salaries

2311

3.000

2.700

Variable remuneration in cash

2312

7.900

6.300

Share-based remuneration system

2313

Compensation

2314

Long-term savings system

2315

3.400

3.700

Other items

2316

600

400

TOTAL

2320

18.200

16.100

MANAGERS

Amount (thousands of euros)

CURRENT

PERIOD

PREVIOUS

PERIOD

Total remuneration received by managers

2325

11.600

11.100

IV. SELECTED FINANCIAL INFORMATION

16. TRANSACTIONS WITH RELATED PARTIES (1/2)

Units: Thousands of euros

RELATED OPERATIONS

REVENUE AND EXPENSES:

CURRENT PERIOD

Significant shareholders

Directors and Managers

People, companies or undertakings of

the Group

Other related parties

Total

1) Financial expenses

2340

2) Leases

2343

3) Reception of services

2344

4) Purchase of goods (completed or in progress)

2345

5) Other expenses

2348

EXPENSES (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9)

2350

6) Financial income

2351

7) Dividends received

2354

8) Provisions of services

2356

9) Sale of goods (completed or in progress)

2357

10) Other revenue

2359

REVENUE (10 + 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18)

2360

OTHER TRANSACTIONS:

CURRENT PERIOD

Significant shareholders

Directors and Managers

People, companies or undertakings of

the Group

Other related parties

Total

Financing agreements, credit and capital contributions (lender)

2372

Financing agreements, credit and capital contributions (borrower)

2375

Guarantees and sureties provided

2381

Guarantees and sureties received

2382

Commitments made

2383

Dividends and other benefits distributed

2386

Other operations

2385

CLOSING BALANCE

CURRENT PERIOD

Significant shareholders

Directors and Managers

People, companies or undertakings of

the Group

Other related parties

Total

1) Clients and commercial debtors

2341

2) Loans and credits granted

2342

3) Other collection rights

2346

TOTAL BALANCE RECEIVABLE (1+2+3)

2347

4) Providors and commercial creditors

2352

5) Loans and credits received

2353

6) Other payments due

2355

TOTAL BALANCE OWED (4+5+6)

2358

IV. SELECTED FINANCIAL INFORMATION

16. TRANSACTIONS WITH RELATED PARTIES (2/2)

Units: Thousands of euros

RELATED OPERATIONS

REVENUE AND EXPENSES:

PREVIOUS PERIOD

Significant shareholders

Directors and Managers

People, companies or undertakings of

the Group

Other related parties

Total

1) Financial expenses

6340

2) Leases

6343

3) Reception of services

6344

4) Purchase of goods (completed or in progress)

6345

5) Other expenses

6348

EXPENSES (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9)

6350

6) Financial income

6351

7) Dividends received

6354

8) Provisions of services

6356

9) Sale of goods (completed or in progress)

6357

10) Other revenue

6359

REVENUE (10 + 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18)

6360

OTHER TRANSACTIONS:

PREVIOUS PERIOD

Significant shareholders

Directors and Managers

People, companies or undertakings of

the Group

Other related parties

Total

Financing agreements, credit and capital contributions (lender)

6372

Financing agreements, credit and capital contributions (borrower)

6375

Guarantees and sureties provided

6381

15

15

Guarantees and sureties received

6382

6

6

Commitments made

6383

Dividends and other benefits distributed

6386

334.070

334.070

Other operations

6385

14,000

14,000

CLOSING BALANCE

PREVIOUS PERIOD

Significant shareholders

Directors and Managers

People, companies or undertakings of

the Group

Other related parties

Total

1) Clientes y deudores comerciales

6341

2) Préstamos y créditos concedidos

6342

3) Otros derechos de cobro

6346

TOTAL SALDO DEDORES (1+2+3)

6347

4) Proveedores y Acreedores comerciales

6352

5) Préstamos y créditos sociales

6353

6) Otras obligaciones de pago

6355

TOTAL SALDOS ACREEDORES (4+5+6)

6358